You are here

Home » Content

Mast Hücreleri

Mast Cells

Journal Name:

  • İnönü Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2004

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Mast cells are were first described by Paul Ehrlich (1879), as being cells that have prominent cytoplasmic granules stained with basic dyes. Mast cells are found resident in tissues throughout the body, particularly in vicinity of blood vessels and nerves. They are numerous under epithelial surfaces, e.g. in the respiratory and gastrointestinal system, and skin, surfaces in intimate contact with microorganisms and allergens in the environment. Mast cells originate from bone marrow stem cells, and enter to the circulation as progenitor cells and subsequently invade into distinct tissues, where they differentiate into two main subtypes of mature mast cells. Proliferation, migration, differentiation, and survive of mast cells are regulated by tissue-derived local factors including stem cell factor. Mast cells are activated by a variety of physical, biological, and chemical stimuli. After activation, mast cells can secrete mediators that either preformed or newly synthesized. Furthermore, mast cells are important sources of many cytokines which effect inflammation, immunity, and other biological processes. Mast cells have a clear and pivotal role in allergic reactions and parasite infections, but also take part in physiological processes such as innate and acquired immunity, tissue repair, angiogenesis, coagulation and fibrinolysis.
Bookmark/Search this post with
Abstract (Original Language): 
İlk kez Paul Ehrlich tarafından tanımlanmış olan mast hücreleri, bazik boyalarla boyanan belirgin sitoplazmik granüllere sahiptir. Mast hücreleri vücuttaki dokularda, özellikle kan damarlan ve sinirlere yakın yerleşimli olarak bulunurlar. Çevredeki mikroorganizma ve allerjenlerle yakın temasın olduğu, solunum ve sindirim sistemi ve deri gibi epitelyal yüzeylerin altında çok sayıdadırlar. Mast hücreleri kemik iliğindeki kök hücrelerden köken alır, dolaşıma öncü hücreler olarak girer ve daha sonra farklı dokularda yerleşerek, iki farklı olgun mast hücresi tipine farklılaşırlar. Mast hücrelerinin çoğalması, göç etmesi, farklılaşması ve yaşaması stem cell faktörü de içeren doku kökenli lokal faktörlerle düzenlenmektedir. Mast hücreleri çeşitli fiziksel, kimyasal ve biyolojik uyanlarla aktive olurlar. Bu hücreler aktive olduktan sonra, önceden yapılmış olan veya yeni sentezledikleri mediatörleri salgılarlar. Mast hücreleri; inflamasyon, bağışıkkk ve diğer biyolojik olaylarda etkileri olan pek çok sitokinin önemli bir kaynağıdırlar. Mast hücreleri, allerjik reaksiyonlar ve paraziter enfeksiyonların yanısıra; doğal ve kazanılmış immünite, doku tamiri, anjiogenez, pıhtılaşma ve fibrinoliz gibi fizyolojik olaylarda da rol oynamaktadırlar.
FULL TEXT (PDF): 
PDF icon arastirmax-mast-hucreleri.pdf
  • 2
109-120
  • Turkish

REFERENCES

References: 

1. Junquera
LC
, Carneiro J. Basic Histology; Wh ed. McGraw-Hill Companies, 2003: 101-115.
2. Bloom GD. A short history of the mast cell. Acta Otolaryngol 1984; 414: 87-92.
3. Riley JF. Functional significance of histamine and heparin in tissue mast cells. Annals New York Academy of Sciences 1963; 103: 151-163.
4. Reite OB. Mast cells/eosinophilic granule cells of teleostean fish: a review focusing on staining properties and functional responses. Fish&Shellfish Immunology 1998; 8: 489-513.
5. Marone G. Control mechanisms of mediator release in human basophils and mast cells. Immunol Invest 1988; 17(7-8): 707-745.
6. Drake-Lee AB, Price J. A review of the morphology of human nasal mast cells as studied by light and electron microscopy. Rhinology 1992; 30: 229-239.
7. Combs JW, Lagunoff D, Benditt EP. Differentiation and proliferation of embryonic mast cells of the rat. J Cell Biol 1965; 25: 577-592.
8. Norrby K. Mast cells and angiogenesis. APMIS 2002, 110; 355-71.
9. Marone G, Galli S J, Kitamura Y. Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. Trends in Immunology 2002; 23 (9): 425-427.
10. Galli SJ, Maurer M, Lanz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999, 11(1): 53-9.
11. Puxeddu I, Piliponsky AM, Bachelet I, Levi-Schaffer F. Mast cells in allergy and beyond. Int J Biochem Cell Biol. 2003; 35(12):1601-7.
12. Abdel-Majid RM, Marshall JS. Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol. 20()4;172(2): 1227-36.
13. Benoist C, Mathis D. Mast cells in autoimmune disease. Nature 2002; 420: 875-878.
14. Rodewald H-R, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science 1996, 271: 818-822.
15. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit\ and expresses aminopeptidase N (CD13). Blood 1999, 94(7): 2333¬2342.
16. Tanaka A, Arai K, Kitamura Y, Matsuda H. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood 1999; 94 (7): 2390-2395.
17. Hermes B, Welker P, Feldmann-Boddeker I, Krger-Krasagakis S, Hartmann K, Zuberbier T, Henz BM. Expression of mast cell growth modulating and chemotactic
factors and their receptors in human cutaneous scars. J Invest Dermatol 2001; 116(3): 387-93.
18. Ashmann LK. The biology of stem cell factor and its receptor c-kit. Int J Biochem Cell Biol. 1999; 31(10):1037-51.
19. Dastych J, Metcalfe DD. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 1994; 152: 213-219.
20. Bischoff SC, Sellge G. Mast cell hyperplasia: Role of cytokines. Int Arch Allergy Immunol 2002; 127: 118-122.
21. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994; 144: 321¬328.
22. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone DP, Liu F-T, Galli SJ, Kawakami T. Regulation of mast cell survival by IgE. Immunity 2001; 14(6): 791¬800.
23. Metcalfe DD, Baram D, Mekori YA. Mast cells. Phys Rev 1997; 77(4): 1033-1079.
24. Metzger H. The high affinity receptor for IgE on mast cells. Clin Exp Allergy 1991; 21(3): 269-79.
25. Nakamura R, Sato Y, Takagi K, Sasaki N, Sawada J, Kitani S, Teshima R. Presence and primary sequence of a high-affinity lgG receptor on canine mastocytoma (CM-MC) cells. Immunogenetics 2003 ; 55 (4): 271-4.
26. Nunez-Lopez R, Escribano L, Schemthaner GH, Prados A, Rodriguez-Gonzalez R, Diaz-Agustin B, Lopez A, Hauswirth A, Valent P, Almeida J, Bravo P, Orfao A. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol. 2003; 120(2): 257-65.
27. Varadaradjalou S, Feger F, Thieblemont N, Hamouda NB, Pleau JM, Dy M, Arock M. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol. 2003 ; 33(4): 899-906.
28. McCurdy JD, Lin TJ, Marshall JS. Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol. 2001 ; 70(6): 977-84.
29. Price KS, Friend DS, Mellor EA, De Jesus N, Watts GF, Boyce JA. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13. Am J Respir Cell Mol Biol. 2003; 28(4):420-7.
30. Forsythe P, Befus AD. CCR3: a key to mast cell phenotypic and functional diversity? Am Am J Respir Cell Mol Biol. 2003 Apr;28(4):405-9.
31. Costa JJ, Weller PF, Galli SJ. The cells of the allergic response: Mast cells, basophils, and eosinophils. JAMA 1997; 278(22): 1815-1822.
32. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004; 146: 1-12.
33. Letourneau R, Rozniecki JJ, Dimitriadou V, Theoharides TC. Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis. J Neuroimmunol. 2003; 145(1-2): 18-26.
34. Dvorak AM, Tepper RI, Weller PF, Morgan ES, Estrella P, Monahan-Earley RA, Galli SJ. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood. 1994;83(12): 3600-12.
35. Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol. 1996; 77(1): 41-54.
36. Kandere-Grzybowska K, Letourneau R, Donclan J, Kempuraj D, Theoharides TC. Interleukin-1 induced vesicular secretion of interleukin-6 without degranulation from human mast cells. J Immunol 2003b; 171:4830-4836.
37. Gurish ME, Austen KF. The diverse roles of mast cells. J Exp Med. 2001; 194(1):F1-F5.
38. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL Heparin is essential for the storage of specific granule proteases in mast cells.. Nature. 1999; 400 (6746): 769-72.
39. Hallgren J, Estrada S, Karlson U, Alving K, Pejler G. Heparin antagonists are potent inhibitors of mast cell tryptase. Biochemistry. 2001; 40 (24): 7342-9.
40. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M, Eriksson I, Ledin J, Hellman L, Kjellen L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature. 1999; 400 (6746):773-6.
41. Pejler G, Karlstrom A. Thrombin is inactivated by mast cell secretory granule chymase.J Biol Chem. 1993 ;268(16):11817-22.
42. Bankl HC, Valent P. Mast cells, thrombosis, and fibrinolysis. The emerging concept. Thrombosis Research 2002; 105: 359-365.
.43. Stenton GR, Vliagoftis H, Befus AD. Role of intestinal mast cells in modulating gastrointestinal pathophysiology. Annals of Allergy, Asthma, &Immunology 1998; 81:1-12.
44. Enerback L. Mast cells in the rat gastrointestinal mucosa I. Effects of fixation. Acta Path et Microbiol Scandinav 1966a; 66: 289-302.
45. Enerback L. Mast cells in rat gastrointestinal mucosa. II. Dye-binding and metachromatic properties. Acta Path et Microbiol Scandinav 1966b; 66: 303-12.
46. Erpek
S
, Otlu A. Tavşan ağız mukozasında mast hücrelerinin dağılımı. Turgut Özal Tıp Merkezi Dergisi 1995; 2(3):258-267.
47. Wingren U, Enerback L. Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. Histochem J 1983;15: 571-587.
48. Marshall JS, Bienenstock J. Mast cells. Springer Semin Immunopathol 1990; 12: 191¬202.
49. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Ann Rev Immunol 1989; 7: 59-76.
50. Irani AA, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy 1989; 19: 143-155.
51. Strobel S, Miller HRP, Ferguson A. Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol 1981; 34: 851-858.
52. Pearse FL, Boulos PB, Lau HYA, Liu WL, Tainsh KR. Functional heterogeneity of human mast cells. Int Arch Allergy Appl Immunol. 1991; 94: 239-40.
119
Erpek
53. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells*. J Immunol 1987; 138: 2611-5.
54. Miller HRP, Walshaw R. Immune reactions in mucous membranes IV. Histochemistry of intestinal mast cells during helminth expulsion in the rat. Am J Pathol 1972; 69(1): 195-205.
55. Drake-Lee AB, Chevreton E, Lowe D. The effects of different fixations on the distribution and numbers of mast cells in patients with nasal polyps. J Laryngol Otol 1988; 102: 1099-1101.
56. Erpek S, Kafkaslı A, Otlu A, Atmaca R. Mast cell density of the human umbilical cord. Journal of Turgut Özal Medical Center 1998; 5(1): 43-46.
57. Bancroft JD, Stevens A. Cytoplasmic granules, organelles and special tissues. In: Bancroft JD, Stevens A, editors. 3rd ed. London: Churchill Livingstone 1990; 637-9.
58. Aldenborg F, Enerback L. Histochemical heterogeneity of dermal mast cells in athymic and normal rats. Histochem J 1988; 20: 19-28.
59. Parwaresch MR, Horny HP, Lennert K. Tissue mast cells in health and disease. Path Res Pract 1985; 179: 439-461.
60. Mendonça VO, Vugman I, Jamur MC. Maturation of adult rat peritoneal and mesenteric mast cells. A morphological and histofluorescence study. Cell Tissue Res 1986; 243: 635-9.
61. Li C-Y. Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry. Leukemia Reseach 2001; 25: 537-541.
62. Arizano N, Koreto O, Iwai Y, Kushima R, Nakao S, Takeoka O. A combined alcian blue-PAS-ABC method for differential staining of mast cells. Acta Histochem Cytochem 1987; 20(1): 101-4.
63. Horny HP, Sillaber C, Menke D, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998; 22: 1132-40.
64. Malaviya R, Ikeda T, Ross E, et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996; 381: 77-80.
65. Maurer M, Echtenacher B, Hultner L, et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med 1998; 188: 2343¬2348.
66. Prodeus AP, Zhou X, Maurer M, et al. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997; 390: 172-175.
67. Brody D, Metcalfe DD. Mast cells: a unique and functional diversity. Clin Exp Allergy 1998 ; 28(10):1167-70.
68. Lantz CS, Boesiger J, Song CH, et al. Role for interIeukin-3 in mast-cell and basophil development and in immunity to parasites. Nature. 1998 ;392(6671):90-3.
69. Puxeddu I, Levi-Schaffer F. Mast cells and tissue remodeling. Rev Fr Allergol Immunol Clin 2002; 42: 16-8.
70. Hiromatsu Y, Toda S. Mast cell and angiogenesis. Microsc Res Tech 2003; 60(1): 64¬9.
71. Kauhanen P, Kovanen PT, Reunala T, Lassila R. Effects of skin mast cells on bleeding time and coagulation activation at the site of platelet plug formation. Thromb Haemost. 1998 ;79(4): 843-7.
72. Bankl HC, Radaszkiewicz T, Klappacher GW, et al. Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand. Circulation. 1995 15; 91(2): 275-83.
73. Kitamura Y, Taguchi T, Yokoyama M, et al. Higher susceptibility of mast-cell-deficient W/WV mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink. Am J Pathol. 1986 ; 122 (3): 469-80.
74. Samoszuk M, Corwin M, Hazen SL. Effects of human mast cell tryptase on the kinetics of blood clotting. Trombosis Research 2003; 109: 153-156.

Thank you for copying data from http://www.arastirmax.com